Investors Research Corp’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,400	Closed	-$39K	–	1126
2019 Q2	$39K	Hold	1,400	–	–	0.02%	539
2019 Q1	$46K	Buy	+1,400	New	+$46K	0.02%	521